Literature DB >> 6571454

Possible lithium-induced extrapyramidal effects in Alzheimer's disease.

P M Randels, L A Marco, N S Hanspal, B Robinson.   

Abstract

Extrapyramidal symptomatology has previously been reported in patients on long-term lithium maintenance. This report emphasizes that, in the presence of organic mental disorder, even brief treatment with lithium may induce severe extrapyramidal signs. Furthermore, toxicity to lithium may occur even though serum lithium levels are at therapeutic levels. Following termination of lithium, symptoms subsided quickly in one patient (five days), but more slowly in the other (16 days). Possible pathophysiology of this phenomenon is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6571454

Source DB:  PubMed          Journal:  Hillside J Clin Psychiatry        ISSN: 0193-5216


  2 in total

1.  Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

Authors:  D P Devanand; Jesse G Strickler; Edward D Huey; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Ipsit V Vahia; Howard Andrews; Melanie M Wall; Gregory H Pelton
Journal:  Contemp Clin Trials       Date:  2018-05-31       Impact factor: 2.226

Review 2.  Mechanism-based treatments for Alzheimer's disease.

Authors:  Peter Davies; Jeremy Koppel
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.